11.09.10
Dr. Manfred Weiler has been appointed vice president of Alliance Development for INC Research, Inc. Based in Geneva, Dr. Weiler will lead the company’s European effort to develop new clinical delivery alliances aimed at improving outsourced drug development.
Prior to joining the company, Dr. Weiler held management positions with SGS Group, where he led its global CRO Business Development department with teams in Europe, the U.S. and Asia. Also, at Qiagen, he was responsible for the strategy, marketing, and future product developments of a joint venture of Qiagen GmbH and Becton Dickinson, Inc.
"We have experienced a very positive response to our alliance partnership program from sponsors of every type and size because of the economic advantages and focus on mutual goals and alignment," said Alistair Macdonald, executive vice president, Strategic Development at INC Research. "Manfred has the right scientific and strategic background to create alliance models that fit the unique requirements represented across the breadth of our current and prospective customer base. We believe clinical delivery alliances are the natural evolution in our industry and we are dedicated on being drivers of that innovation."
Prior to joining the company, Dr. Weiler held management positions with SGS Group, where he led its global CRO Business Development department with teams in Europe, the U.S. and Asia. Also, at Qiagen, he was responsible for the strategy, marketing, and future product developments of a joint venture of Qiagen GmbH and Becton Dickinson, Inc.
"We have experienced a very positive response to our alliance partnership program from sponsors of every type and size because of the economic advantages and focus on mutual goals and alignment," said Alistair Macdonald, executive vice president, Strategic Development at INC Research. "Manfred has the right scientific and strategic background to create alliance models that fit the unique requirements represented across the breadth of our current and prospective customer base. We believe clinical delivery alliances are the natural evolution in our industry and we are dedicated on being drivers of that innovation."